FDA recall D-0241-2026

Product

Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03

Reason for recall

Presence of particulate matter: potential presence of metal particulates in the product.

Distribution

Nationwide in the USA

Key facts

Status

Ongoing

Initiation date

2025-12-12

Report date

2025-12-31

Voluntary/Mandated

Voluntary: Firm initiated

Location

Wilson, NC, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0241-2026